Showing results (71-80 of 4,981) with videos related to

Sort By:
Pageof 499
Biochemical Pharmacology|July 15, 1997
GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatumZ J Dong, L J Chen, G Z Jin, et al.
Life Sciences|January 11, 1992
Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatmentS X Xu, F J Monsma, D R Sibley, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1975
Dopamine receptor binding in the corpus striatum of mammalian brainD R Burt, S J Enna, I Creese, et al.
European Journal of Pharmacology|April 1, 1979
Opiate receptor binding affected differentially by opiates and opioid peptidesS R Childers, I Creese, A M Snowman, et al.
Life Sciences|November 18, 1985
Up-regulation of serotonergic binding sites labeled by [3H]WB4101 following fimbrial transection and 5,7-dihydroxytryptamine-induced lesionsA L Morrow, A B Norman, G Battaglia, et al.
European Journal of Pharmacology|February 11, 1986
Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatumE J Hess, G Battaglia, A B Norman, et al.
The American Journal of Psychiatry|January 1, 1980
Low neuroleptic serum levels in patients receiving fluphenazine decanoateL E Tune, I Creese, J T Coyle, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1991
N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brainS X Xu, Y Hatada, L E Black, et al.
The Journal of Nervous and Mental Disease|January 1, 1981
Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patientsL E Tune, I Creese, J R DePaulo, et al.
Psychiatry Research|July 1, 1979
Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observationsH M Calil, D H Avery, L E Hollister, et al.
Pageof 499